Drug · DIN 02419548
SPC-EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 11, 2026; first marketed September 15, 2014.
- Drug Identification Number (DIN)
- 02419548
- Company (DIN owner)
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- March 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 11, 2026: NOC 37078Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Change in product name
- August 19, 2024: NOC 33830Abbreviated New Drug Submission (ANDS) · Administrative: Change in manufacturer and product name. Update to Product Monograph (to align with CRP approved PM) . Update to package labels
- September 15, 2014: NOC 16070Abbreviated New Drug Submission (ANDS)